Article

New Biosimilar Under Review in Top Specialty Pharmacy News

Author(s):

Davy James, Managing Editor

Catch up with any news you missed this week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
In Control Room Doctor and Radiologist Discuss Diagnosis while Watching Procedure and Monitors Showing Brain Scans Results, In the Background Patient Undergoes MRI or CT Scan Procedure.
June 27th 2025

Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Water coming from a faucet - Image credit: Ajax9 | stock.adobe.com
June 25th 2025

Is Fluoride Friend or Foe?

Jim Ruble, PharmD, JD
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
FDA Approves Dupilumab for Treatment of Bullous Pemphigoid
June 20th 2025

FDA Approves Dupilumab for Treatment of Bullous Pemphigoid

Aislinn Antrim, Managing Editor
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
June 19th 2025

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Gillian McGovern, Associate Editor